Skip to content
naulon
Not checkedNot checked for notices yet.

Growth, immune responses and protection of Nile tilapia Oreochromis niloticus immunized with formalin-killed Streptococcus agalactiae serotype Ia and III vaccines

Atchariya Suwannasang, Naraid Suanyuk, Akkarawit Issaro and 4 more

Songklanakarin Journal of Science and Technology (SJST) · 2017

doi:10.14456/sjst-psu.2017.47 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

The protective efficacy of formalin-killed Streptococcus agalactiae (Group B Streptococcus, GBS) serotype Ia (GBS-Ia) and III (GBS-III) vaccines were assessed in Nile tilapia (Oreochromis niloticus). The fish with an average weight of 34.45± 0.08 g were immunized by intraperitoneal (i.p.) injection with 4 different formalin-killed vaccines prepared from GBS-Ia (1x1010 CFU/mL), GBS-III (1x1010 CFU/mL), and combined GBS-Ia and GBS-III in an equal volume at final concentrations 1x1010 CFU/mL and 2x1010 CFU/mL in comparison with the non-immunized control group. At 2 and 4 weeks post vaccination, no significant differences were observed (p>0.05) among treatments in growth performance or haemato-immunological parameters, except the increased red blood cell at 2 weeks. Significantly increased antibody titers (p<0.05) against GBS-Ia and GBS-III antigens were noted in the groups immunized with homologous GBS vaccines, whereas the group reacted with heterologous GBS antigen showed less antibody titer as compared with the control group. The vaccination experiment indicated that i.p. injection of Nile tilapia with formalin-killed cells prepared from GBS-Ia or GBS-III provides significant protection, with relative percent survival (RPS) value of 52.17 to 71.42%, against a challenge with the homologous serotype isolate, whereas the RPS in fish challenged with a heterologous serotype isolate varied from 20.00 to 53.57%. These results suggested that vaccines from either GBS-Ia or GBS-III have insufficient cross-protective efficacy against the other serotypes. However, a mixed vaccine produced from both GBS serotypes Ia and III provided significant protection with 65.00 to 95.66% RPS which could be an excellent vaccine to protect fish against streptococcosis caused by both GBS serotypes Ia and III.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.